Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rui-Feng Xu
Institution:
Abbisko Therapeutics Co., Ltd. (China)
Observed institution:
Abbisko Therapeutics Co., Ltd. (China)
ORCID:
0009-0003-1724-7085
Observed ORCID:
0009-0003-1724-7085
OpenAlex ID:
A5113060388
EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023
·
Bin Shen
, Jue-Ping Shi
, et al.
·
Molecular Cancer Therapeutics
·
15
Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023
·
Bin Shen
, Jue-Ping Shi
, et al.
Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023
·
Bin Shen
, Jue-Ping Shi
, et al.
Supplementary Data from EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
2023
·
Bin Shen
, Jue-Ping Shi
, et al.
PDF
Show more works
View as search
Works count:
4
Citation count:
15
H-index:
1
I10-index:
1
Year
Topic
Type